Improvement in Neuropathy Specific Quality of Life in Patients with Diabetes after Vitamin D Supplementation
Uazman Alam, Asher Fawwad, Fariha Shaheen, Bilal Tahir, Abdul Basit, and Rayaz A. Malik,
Gait & Posture 58 (2017) 72–77
Introduction
ÅëÁõÀÌ µ¿¹ÝµÈ ´ç´¢º´¼º ½Å°æº´ÁõÀº ¹ß ´Ù¸®¿¡ Àú¸°°¨, Ÿ´ÂµíÇÑ ¾ç»ó, Ȳö°Å¸² µî°ú °°Àº ÅëÁõÀ» ¾ß±âÇÏ¸ç »îÀÇ ÁúÀ» Å©°Ô ÀúÇϽÃŲ´Ù. ºñŸ¹Î D °áÇÌ ±× ÀÚü°¡ ´ç´¢º´¼º ½Å°æº´Áõ°ú ¹ÐÁ¢ÇÑ ¿¬°ü°ü°è°¡ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÇÑ ¿¬±¸¿¡ µû¸£¸é ºñŸ¹Î D °áÇÌÀÌ ´ç´¢º´¼º ½Å°æº´ÁõÀÌ Àִ ȯÀÚÀÇ ÃÖ´ë 82%¿¡¼ ¹ß»ýÇß´Ù°í º¸°íÇÏ¿´´Ù. ¶ÇÇÑ ÃÖ±Ù, ºñŸ¹Î D °áÇÌÀÌ ´ç´¢º´¼º ½Å°æº´ÁõÀÇ µ¶¸³ÀûÀÎ À§Çè ÀÎÀÚ·Î º¸°íµÇ¾ú´Ù. º» ¿¬±¸ÀÇ ¸ñÀûÀº ÅëÁõÀÌ µ¿¹ÝµÈ ´ç´¢º´¼º ½Å°æº´Áõ ȯÀÚ¿¡°Ô °í¿ë·® ºñŸ¹Î D ±ÙÀ° ÁÖ»ç Ä¡·á¸¦ ½ÃÇàÇÏ¿´À» ¶§ »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÏ¿© Æò°¡ÇÏ°íÀÚ ÇÏ¿´´Ù.
Methods
- 18¼¼ ÀÌ»óÀÇ Áõ»óÀÌ µ¿¹ÝµÈ ´ç´¢º´¼º ½Å°æº´Áõ ȯÀÚ.
- HbA1C ¡Â 11 % with no comorbidities.
- ±ÙÀ° ³» ºñŸ¹Î D3 600,000 U ´ÜÀÏ ÁÖ»ç ÈÄ ¸Å 4ÁÖ¸¶´Ù ÃÑ 5¹ø follow-upÇÔ.
- Serum 25(OH)D ÃøÁ¤ÇÔ.
- Endocrine Society Clinical Practice Guideline, 2011¿¡ ±Ù°ÅÇÏ¿© Deficiency as 25(OH)D < 20 ng/ml, Insufficiency as 25(OH)D 20-30 ng/ml, Adequacy as 25(OH)D ¡Ã 30 ng/ml·Î Á¤ÀÇ ³»¸².
Neuropathy Specific Quality of Life Questionnaire (NeuroQoL)
- 6°³ÀÇ ¼ÒºÐ·ù·Î ³ª´©¾îÁø 27°¡ÁöÀÇ ¼³¹® ½ÃÇàÇÔ.
1) Painful symptoms and paresthesia
2) Reduction or loss of ability to feel temperature and/or objects with the feet
3) Unsteadiness while standing/ walking
4) Limitation in daily activities
5) Interpersonal problems, for example, physical/emotional dependence on others
6) Emotional distress
- Áõ»ó ºóµµ¸¦ 1ºÎÅÍ 5±îÁö ºÐ·ùÇÔ(1:¡±never¡±, 5: ¡°all the time¡±)
Results
- 40% ȯÀÚ¿¡¼ ºñŸ¹Î D deficient, 17% ȯÀÚ¿¡¼ ºñŸ¹Î D insufficient, 43% ȯÀÚ¿¡¼ ºñŸ¹Î D sufficient ¼Ò°ß °üÂûµÊ (Table 1 ÂüÁ¶)
Effect of Treatment with Vitamin D
- ºñŸ¹Î D Ä¡·á ÈÄ 25(OH)D Áõ°¡»Ó¸¸ ¾Æ´Ï¶ó Calcium, HDL Áõ°¡ ¹× HbA1c °¨¼Ò °üÂûµÊ (Table 2 ÂüÁ¶).
- ºñŸ¹Î D Ä¡·á ÈÄ visit 3ºÎÅÍ NeuroQoLÀÇ emotional distress ¿µ¿ªÀÇ ÀÇ¹Ì Àִ ȣÀü °üÂûµÊ (Table 3 ÂüÁ¶).
- ºñŸ¹Î D Ä¡·á ÈÄ QoL¿¡¼ ¹ß ¹®Á¦¿¡ ´ëÇÑ È¯ÀÚÀÇ ÀνĿ¡¼ ¡°quite a lot¡±°ú ¡°very much¡±¶ó°í ¹ÝÀÀÇÏ´Â ÆÛ¼¾Æ®°¡ Å©°Ô °¨¼ÒÇÔ.
- ºñŸ¹Î D Ä¡·á ÈÄ QoL¿¡¼ ¡°poor QoL¡± ÀÀ´äÀÌ 5.2%¿¡¼ 0.7%·Î ´ëÆø °¨¼ÒÇßÀ¸¸ç ¡°excellent QoL¡± ÀÀ´äÀÌ 1.5%¿¡¼ 7.4%·Î Áõ°¡ÇÔ (Fig 1 ÂüÁ¶).
Conclusion
´ç´¢¿Í ÅëÁõÀÌ µ¿¹ÝµÈ ´ç´¢º´¼º ½Å°æº´ÁõÀº »îÀÇ ÁúÀÇ Ç϶ôÀ» ¾ß±â½ÃŲ´Ù. ÀÌ ¿¬±¸ÀÇ ÁÖ¿ä °á°ú´Â °í¿ë·®ÀÇ ºñŸ¹Î D ´ÜÀÏ ÁÖ»ç Ä¡·á ÈÄ NeuroQoLÀÇ emotional distress ¿µ¿ª¿¡¼ ÀÇ¹Ì Àִ ȣÀüÀÌ °üÂûµÇ¾úÀ¸¸ç, »îÀÇ Áú¿¡ ´ëÇÑ Àü¹ÝÀûÀΠȯÀÚÀÇ ÀνÄ, ƯÈ÷ ºñŸ¹Î D Ä¡·á ÈÄ ¹ß ¹®Á¦¿¡ ´ëÇÑ È¯ÀÚ ÀνĿ¡ ÀÖ¾î¼ÀÇ °³¼±À» º¸¿©ÁÖ¾ú´Ù. ¶ÇÇÑ Ç÷Áß ºñŸ¹Î D ¼öÄ¡»Ó¸¸ ¾Æ´Ï¶ó HbA1c¿Í HDLÀÇ È£ÀüÀÌ °üÂûµÇ¾ú´Ù.